EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Extrapyramidal and anticholinergic reactions in an adolescent patient: a case for pharmacogenetic consideration

Iris Žunić Išasegi, Ivana Stefanović, Marta Okružnik Želalić, Livija Šimičević, Lana Ganoci, Maja Živković, Ivan Begovac, Nada Božina

Biochemia medica · 15.06.2026 · 36 (2) · 361-368

DOI: 10.11613/bm.2026.020902 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Biochemia medica, online erschienen am 15.06.2026. Verfasst von Iris Žunić Išasegi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Child and Adolescent Psychiatry, University Hospital Centre Zagreb, Zagreb, Croatia. Hauptthemen laut MEDLINE: Basal Ganglia Diseases, Pharmacogenetics, Cholinergic Antagonists, Anticholinergic Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adolescent patients with borderline personality traits present a significant clinical challenge due to their polymorphic symptomatology occurring together with ongoing psychological and physiological development. While psychotherapy remains the first-line treatment, it is often combined with different psychopharmacological medications. This case report presents a 17.5-year-old female adolescent who developed extrapyramidal symptoms (EPS) following the addition of fluphenazine to her therapy, which had been modified due to deteriorating psychiatric symptoms. After the resolution of the EPS, the patient developed anticholinergic syndrome within a few days. Pharmacogenetic testing showed genetic variations associated with modified drug and dopamine metabolism, which may have contributed to her increased predisposition to drug adverse effects. This case highlights the complexity of psychopharmacological management in adolescents with multidimensional symptomatology and emphasizes the potential value of integrating pharmacogenetic data to guide optimal treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Basal Ganglia DiseasesPharmacogeneticsCholinergic AntagonistsAnticholinergic SyndromeHumansFemaleAdolescent

Stichwörter der Autor:innen

anticholinergic syndromeborderline personality traitschild and adolescent psychiatryextrapyramidal symptomspharmacogenetics

Substanzen

Cholinergic Antagonists

Autor:innen und Institutionen

  • Department of Child and Adolescent Psychiatry, University Hospital Centre Zagreb, Zagreb, Croatia.
  • Division of Pharmacogenomics and Therapy Individualization, Department of Laboratory Diagnostics, University Hospital Centre Zagreb, Zagreb, Croatia.
  • School of Medicine, University of Zagreb, Zagreb, Croatia.
  • Department of Psychiatry and Psychological Medicine, University Hospital Centre Zagreb, Zagreb, Croatia.

Zitieren

APA

Žunić Išasegi, I., Stefanović, I., Okružnik Želalić, M., Šimičević, L., Ganoci, L., Živković, M., Begovac, I., & Božina, N. (2026). Extrapyramidal and anticholinergic reactions in an adolescent patient: a case for pharmacogenetic consideration. Biochemia medica, 36(2), 361-368. https://doi.org/10.11613/bm.2026.020902

Vancouver

Žunić Išasegi I, Stefanović I, Okružnik Želalić M, Šimičević L, Ganoci L, Živković M, et al. Extrapyramidal and anticholinergic reactions in an adolescent patient: a case for pharmacogenetic consideration. Biochemia medica. 2026;36(2):361-368. doi:10.11613/bm.2026.020902

BibTeX
@article{uniIasegi2026,
  author = {Žunić Išasegi, Iris and Stefanović, Ivana and Okružnik Želalić, Marta and Šimičević, Livija and Ganoci, Lana and Živković, Maja and Begovac, Ivan and Božina, Nada},
  title = {Extrapyramidal and anticholinergic reactions in an adolescent patient: a case for pharmacogenetic consideration},
  journal = {Biochemia medica},
  year = {2026},
  volume = {36},
  number = {2},
  pages = {361--368},
  doi = {10.11613/bm.2026.020902}
}
Kostenlos starten →